4595.T
MIZUHO MEDY CO.,LTD.
スタンダード · 医薬品 · 医薬品 · JP
JPY 1,715.00
−0.46%Year over year
Reported trailing growth
- Revenue
- -4.6%
- EBITDA
- —
- EBIT
- -10.5%
- EPS
- -9.2%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +5.6%
- EBITDA
- —
- EPS
- -0.9%
Three-year CAGR
- Revenue
- -13.8%
- EBITDA
- -24.2%
- EBIT
- -25.2%
- Net income
- -24.1%
- EPS
- -39.8%
- Free cash flow
- -34.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026